...ests are available in 14 configurations including ...g Microgenics Antibody Technology, the SureStep&tr... immunoassay targeted to detect MDMA that has an a...ity to any isomer of methamphetamine or amphetamin...
...ests are available in 14 configurations including ...g Microgenics Antibody Technology, the SureStep&tr... immunoassay targeted to detect MDMA that has an a...ity to any isomer of methamphetamine or amphetamin...
AccuSign® DOA Series Opiates Test
...ests are available in 14 configurations including ...g Microgenics Antibody Technology, the SureStep&tr... immunoassay targeted to detect MDMA that has an a...ity to any isomer of methamphetamine or amphetamin...
Medicine Products:(Date:10/15/2008)... TomoTherapy Incorporated (NASDAQ: TOM..., recently hosted a symposium on the clinical use ...iosurgery (SRS) and stereotactic body radiation th...iArt system’s inherent suitability for stere...ty and homogeneity; presented clinical work on a v...
(Date:10/15/2008)...ct. 15 /PRNewswire-FirstCall/ -- Affiliated Comput...he award of a $27 million, 21-month,contract for t...on System,(MMIS) for the state of Alaska,s Departm... October 2007, ACS signed a $130 million, 10-year ... and operate a new MMIS system.,Now, as part of a ...
(Date:10/15/2008)...a., Oct. 15 /PRNewswire-USNewswire/ -- Clinical Ca...nnovative online, print, and live,medical educatio...ment with,the American Association for the Study o...al provider of its unique Conference Coverage of A...n San Francisco, California,October 31 - November...
(Date:10/15/2008)... to help prevent a catastrophe of epic proportions...ho Pays for Your Health Care, NEW YORK, Oct. 15 /...elling and informative. His vision of, empowering...ology,having transparent costs, and integrating s... the system from one that fails to one that...
Breaking Medicine News(10 mins):Health News: Grupo IMO Hosts Symposium on Use of TomoTherapy for Stereotactic Radiosurgery and Stereotactic Body Radiation Procedures : Experts Detail HiArt Platform Advantages for Treatment of Brain, Lung, Pancreatic and Metastatic Cancers 2Health News: Grupo IMO Hosts Symposium on Use of TomoTherapy for Stereotactic Radiosurgery and Stereotactic Body Radiation Procedures : Experts Detail HiArt Platform Advantages for Treatment of Brain, Lung, Pancreatic and Metastatic Cancers 3Health News:ACS Signs $27 Million Contract with Alaska to Transition Fiscal Agent Services for State Medicaid Program 2Health News:ACS Signs $27 Million Contract with Alaska to Transition Fiscal Agent Services for State Medicaid Program 3Health News:American Association for the Study of Liver Diseases Enters Into Agreement With Clinical Care Options as Its Authorized Online Conference Coverage Provider for the Liver Meeting(R) 2008 2Health News:With the Economy of the United States at a Turning Point, Health Care Could Be Our Next Serious Crisis ... 2(Date:10/13/2008)...)-F Surface Treatment Maximizes,Endothelialization...ng-Term,Dual Antiplatelet Therapy, WASHINGTON, Oc...day,s,"Innovative Devices and Futuristic Therapies...diovascular Therapeutics (TCT) scientific,symposiu...tion, presented,12-month follow-up data from the A...
(Date:10/13/2008)...e Cancer Populations Facilitates ... 13 /- Rubicon Genomics, Inc. today,a...fy DNA samples for The,Cancer Atlas Genome Project...tandardize total genomic,DNA from 3,000 tissue and...enomePlex(TM) Whole Genome Amplification technolog...
(Date:10/12/2008)...ts designed for more uniform drug ...NGTON, Oct. 12 /- Boston,Sc... comprehensive data from,the TAXUS ATLAS clinical ...nter, single-arm, historically controlled trials, ...Eluting Stent System in a variety of,lesions and p...
(Date:10/10/2008)...wire/ -- Diplomat Specialty,Pharmacy announced tod...ecialty Pharmacy to be one of only three sites to ...imization Study for Multiple Sclerosis (TOP MS)., ...mine the benefits of a,specialty pharmacy therapy ...tient outcomes. Targeted patient outcomes will inc...
Breaking Medicine Technology:12-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 212-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 312-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 4Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 2Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 3Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 2Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 3Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 4Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 5Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 6Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS) 2AARP Deeply Disappointed by Supreme Court Decision on Retiree Health Care Benefits 14970 1AARP Deeply Disappointed by Supreme Court Decision on Retiree Health Care Benefits 14970 2Cantel Medical Corp and National Safety Council Launch Joint Initiative to Prepare Businesses and Individuals for Flu Pandemic 14968 1Cantel Medical Corp and National Safety Council Launch Joint Initiative to Prepare Businesses and Individuals for Flu Pandemic 14968 2Cantel Medical Corp and National Safety Council Launch Joint Initiative to Prepare Businesses and Individuals for Flu Pandemic 14968 3WellPoints Health Plans to Cover Newly Approved Cancer Treatment 14966 1WellPoints Health Plans to Cover Newly Approved Cancer Treatment 14966 2Stress On The Campaign Trail One Issue All The Candidates Agree On 14964 1Stress On The Campaign Trail One Issue All The Candidates Agree On 14964 2...SINESS WIRE)--May 17, 2007 - Salix,Pharmaceuticals...of,18 investigator-initiated trials related to the... Disease Week(R) 2007, which will be,held May 19-2...largest and most prestigious meeting in the world ...re than 16,000 physicians,researchers and academi...
...SIS 301012 produced at least 45% additional,reduct...imally-tolerated lipid-lowering therapies, CARLSBA...Isis,Pharmaceuticals, Inc. announced updated resul... 301012 in patients with homozygous,familial hyper...ere,presented in March at the of Cardiology Annual...
Other Medicine Technology:Salix Pharmaceuticals Previews Digestive Disease Week 2007 2Salix Pharmaceuticals Previews Digestive Disease Week 2007 3Salix Pharmaceuticals Previews Digestive Disease Week 2007 4Salix Pharmaceuticals Previews Digestive Disease Week 2007 5Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 2Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 3Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 4Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 5